Literature DB >> 1332156

Macrophage activation by OM-85 BV.

J Mauël1.   

Abstract

Peritoneal or bone-marrow-derived murine macrophages were exposed for 24 h in vitro to dilutions of the bacterial extract OM-85 BV, in the presence or absence of other added compounds [macrophage-activating factor (MAF), recombinant murine interferon-gamma (IFN-gamma)]. Various metabolic responses and functional activities were then measured. Glucose oxidation through the hexose monophosphate shunt pathway was markedly stimulated in OM-85 BV-treated macrophages compared to control macrophages. Similarly, OM-85 BV primed macrophages for superoxide production upon triggering by phorbol myristate acetate. Both effects were further enhanced by simultaneous treatment of the cells with MAF with OM-85 BV. The bacterial extract also induced macrophages to release large amounts of nitrite (a marker of the activated state). As regards functional responses, coincubation with MAF and OM-85 BV activated macrophages to destroy target cells as well as intracellular microorganisms; in the latter case, similar results were obtained when MAF was replaced by IFN-gamma. In all these tests, the possibility that the observed effects were due to contamination of the bacterial extracts by endotoxin could be excluded. The above results indicate that OM-85 BV induces metabolic and functional properties in macrophages that are characteristic of the activated state and are important for host defence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332156     DOI: 10.1159/000196125

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  5 in total

1.  OM85-BV induced the productions of IL-1β, IL-6, and TNF-α via TLR4- and TLR2-mediated ERK1/2/NF-κB pathway in RAW264.7 cells.

Authors:  Hong Luan; Qian Zhang; Le Wang; Chuanxiao Wang; Miao Zhang; Xiaoli Xu; Huan Zhou; Xing'ai Li; Qing Xu; Fan He; Jin Yuan; Yongman Lv
Journal:  J Interferon Cytokine Res       Date:  2014-03-07       Impact factor: 2.607

2.  Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.

Authors:  R Keul; M Roth; E Papakonstantinou; M Nauck; A P Perruchoud; L H Block
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

3.  Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses.

Authors:  A Rial; D Lens; L Betancor; H Benkiel; J S Silva; J A Chabalgoity
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 4.  Immunologic aspects of otitis media.

Authors:  Joel M Bernstein
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

5.  Effect of OM-85 BV on reducing bronchiectasis exacerbation in Chinese patients: the iPROBE study.

Authors:  Jinming Gao; Lun Li; Nan Jiang; Ying Liao; Lingfei Kong; Yuanlin Song; Jinfu Xu; Jie Cao; Yuping Li; Chengli Que; Roy A Pleasants
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.